Followers | 131 |
Posts | 14996 |
Boards Moderated | 0 |
Alias Born | 06/04/2018 |
Saturday, December 28, 2019 11:30:16 AM
When first learning of a proposed acquisition, it can be easy to subconsciously slip over the word "proposed" as linguistic fodder. But although many acquisitions earn regulatory approval relatively quickly, some trip up enough alarm bells among trade authorities to significantly slow closing or...
Got this from QGEN - What Happens Next for Illumina and Pacific Biosciences?
Recent QGEN News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/16/2025 10:00:11 PM
- QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million • Business Wire • 01/16/2025 09:05:00 PM
- QIAGEN gibt Details zum Abschluss des synthetischen Aktienrückkaufs über bis zu rund $300 Mio. bekannt • Business Wire • 01/16/2025 09:05:00 PM
- QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast • Business Wire • 01/15/2025 01:13:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/13/2025 08:46:36 PM
- QIAGEN zahlt rund 300 Millionen Dollar durch einen synthetischen Aktienrückkauf an seine Aktionärinnen und Aktionäre zurück • Business Wire • 01/12/2025 06:05:00 PM
- QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase • Business Wire • 01/12/2025 06:05:00 PM
- Tiefere Erkenntnisse aus biologischen Proben: QIAGEN erweitert digitales PCR-System QIAcuity um Multiplexing-Funktionen höherer Ordnung • Business Wire • 01/10/2025 06:30:00 AM
- QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples • Business Wire • 01/10/2025 06:30:00 AM
- QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care • Business Wire • 01/09/2025 09:05:00 PM
- QIAGEN erhält U.S.-Zulassung für erstes QIAstat-Dx Mini-Panel für Magen-Darm-Infektionen zur Unterstützung der ganzjährigen ambulanten Versorgung • Business Wire • 01/09/2025 09:05:00 PM
- QIAGEN liefert genomische Inhalte für britische Initiative zur Genomsequenzierung von 100.000 Neugeborenen • Business Wire • 01/07/2025 09:05:00 PM
- QIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content • Business Wire • 01/07/2025 09:05:00 PM
- QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data • Business Wire • 12/12/2024 09:05:00 PM
- QIAGEN führt KI-Erweiterung für Ingenuity Pathway Analysis zur automatisierten Interpretation biologischer Daten ein • Business Wire • 12/12/2024 09:05:00 PM
- QIAGEN erreicht Meilenstein: Über 1.000 platzierte EZ2 Connect-Systeme zur Probenvorbereitung treiben Laborautomatisierung voran • Business Wire • 12/05/2024 09:05:00 PM
- QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation • Business Wire • 12/05/2024 09:05:00 PM
- QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing • Business Wire • 11/28/2024 11:00:00 AM
- QIAGEN stärkt QIAstat-Dx mit neuem Standort in Barcelona zur Wachstumsbeschleunigung bei Tests für Infektionskrankheiten und Präzisionsmedizin • Business Wire • 11/28/2024 11:00:00 AM
- QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis • GlobeNewswire Inc. • 11/27/2024 09:05:00 PM
- QIAGEN collaborates with McGill University to advance microbiome research • GlobeNewswire Inc. • 11/12/2024 09:05:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/07/2024 04:46:20 PM
- QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook • GlobeNewswire Inc. • 11/06/2024 09:05:00 PM
- QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics • GlobeNewswire Inc. • 11/04/2024 06:30:00 AM
- QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment • GlobeNewswire Inc. • 10/29/2024 06:30:00 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM
VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM
UAV Corp (OTC: UMAV) Engages Legal Counsel to Initiate Uplisting Process with Ultimate Goal of NASDAQ Listing • UMAV • Jan 15, 2025 8:30 AM
HealthLynked Welcomes Jeremy Daniel as Chief Financial Officer • HLYK • Jan 15, 2025 8:00 AM